Proliferating Cell Nuclear Antigen (PCNA) is a 36 kDa homotrimeric protein critical for DNA replication, repair, and chromatin remodeling. PCNA monoclonal antibodies are engineered to bind specific epitopes of this protein, enabling its detection and functional analysis in research and clinical diagnostics. These antibodies are widely used to assess cell proliferation rates, study DNA repair mechanisms, and identify cancer biomarkers .
PCNA acts as a sliding clamp for DNA polymerases during replication and repair, forming a ring-shaped structure around DNA to enhance processivity. Key interactions include:
DNA replication: Scaffolds polymerases (δ, ε, η) and ligases .
DNA repair: Coordinates repair pathways (base excision, nucleotide excision, mismatch repair) .
Cell cycle regulation: Overexpression correlates with S-phase progression and cancer virulence .
PCNA monoclonal antibodies are employed across diverse methodologies:
PC10 (Clone PC10): Binds linear epitopes in the aa 111–125 region, showing nuclear localization and simpler epitope recognition compared to other antibodies (e.g., 19A2, 19F4) .
1C11: Targets aa 151–261, with reactivity in human, mouse, rat, and rabbit .
mAb14: Unique antibody detecting cell surface PCNA in lymphoma cells, distinct from nuclear-targeting antibodies .
Ampulla of Vater cancer: PCNA-positive rates >40% correlate with poor prognosis and metastasis .
Cutaneous T-cell lymphoma: mAb14 identifies malignant cells in Sézary syndrome via cell surface PCNA detection .
PCNA-targeting peptides: Induce apoptosis in neuroblastoma, prostate, breast, and bladder cancers .
mAb14: Blocks NKp44-PCNA interaction, enhancing NK cell activity against lymphoma .
Epitope masking: Formalin fixation may obscure nuclear PCNA epitopes, requiring antigen retrieval .
Cross-reactivity variability: PC10 detects non-human primates and Drosophila, while 1C11 lacks primate reactivity .
Cell surface vs. nuclear detection: mAb14 distinguishes cancer-specific membrane PCNA from nuclear PCNA .
This PCNA monoclonal antibody targets proliferating cell nuclear antigen (PCNA), an auxiliary protein for DNA polymerase delta. PCNA plays a crucial role in regulating eukaryotic DNA replication by enhancing polymerase processivity during leading strand elongation. It significantly stimulates the 3'-5' exonuclease and 3'-phosphodiesterase activities of APEX2, but not its apurinic-apyrimidinic (AP) endonuclease activity. Stimulation of APEX2 activity requires PCNA to be pre-loaded onto DNA. PCNA is essential for the DNA damage response (DDR), strategically positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways. It functions as a scaffold, recruiting DDR proteins to facilitate DNA replication completion post-damage and promote post-replication repair. Monoubiquitinated PCNA recruits translesion synthesis (TLS) polymerases, while Lys-63-linked polyubiquitination of PCNA is involved in error-free pathways utilizing recombination mechanisms for lesion bypass.